Learn about once-daily dosages for AUSTEDO XR® (deutetrabenazine) extended release tablets for Tardive Dyskinesia (TD). See safety info and Boxed Warning.

Feb 28, 2025 · Dosing Information The dose of AUSTEDO XR and AUSTEDO is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. …

Learn about once-daily AUSTEDO XR for the treatment of TD. See Prescribing Information, including Boxed Warning.

Sep 25, 2025 · Austedo and Austedo XR treat tardive dyskinesia and chorea related to Huntington’s disease in adults. The dosage varies depending on the condition. Austedo …

When first prescribed to patients who are not being switched from tetrabenazine, the recommended starting dose of deutetrabenazine (Austedo) is 6 mg administered orally once …

Aug 20, 2025 · Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor). Austedo tablets are taken twice daily, and the Austedo XR (extended-release) …

Titrate at weekly intervals by 6 mg per day based on reduction of chorea or tardive dyskinesia, and tolerability, up to a maximum recommended daily dosage of 48 mg (2.1) Administer …

May 29, 2024 · U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular …

Jun 15, 2024 · Deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a vesicular monoamine transporter 2 (VMAT) inhibitor, was originally approved as a twice-daily treatment for chorea …

Titrate at weekly intervals by 6 mg per day based on reduction of chorea or tardive dyskinesia, and tolerability, up to a maximum recommended daily dosage of 48 mg (2.1) Administer …